REGISTRATION

Category1 Registration Type Fee
Club Member CSCC Members $150.00 plus applicable taxes
  Non-Members $175.00 plus applicable taxes
Single Roundtable CSCC Members $25.00 plus applicable taxes
  Non-Members $30.00 plus applicable taxes

All CSCC Education Roundtables will be held on Thursdays and will be one (1) hour in length.
Eastern Pacific Mountain Central Atlantic Newfoundland
ON, QC BC AB, SK* MB, ON (West) NB, NS, PE, Lab NL
11:30-12:30 08:30-09:30 09:30-10:30 10:30-11:30 12:30-13:30 13:30-14:30
14:00-15:00 11:00-12:00 12:00-13:00 13:00-1400 15:00-16:00 16:00-17:00
* SK - During daylight savings time; otherwise one hour later

Register HERE Today!

1Save today! Club members are entitled to join any or all of the Roundtables. Register once only once automatically receive an invitation for each Roundtable and access to the slides and recordings of past roundtables for the current year.

  • Registration is by pre-payment only using the online registration form.  
  • Each registration is restricted to one (1) phone line; you may have as many participants using that line as you wish.
  • Participants will be sent a 1-800 phone number for the audio and an internet url to view the slides.

 

2018-2019 SCHEDULE

Time

  Date  Time (Eastern) Presenter(s) Topic
 1 September 27, 2018  11:30-12:30  Graham Segal MD  The Need for Clinical Pathology Consultation in Primary Care
 2 October 11, 2018  14:00-15:00  Vincent DeGuire  A New National Program for Quality Indicators Monitoring in Laboratory Medicine 
 3 October 25, 2018  11:30-12:30  Hans Frykman Introduction to Genomics 
 4 November 8, 2018  11:30-12:30  Tracy Stockle Cell Free Circulating Tumour DNA: Applications in Oncology
 5 November 22, 2018  14:00-15:00  Ronald A. Booth The Role of Troponin Algorithms in Diagnosis of Acute Coronary Syndrome
 6 December 6, 2018  11:30-12:30  Trefor Higgins  Harmonized Reference Intervals ... Holy grail or wishful thinking? 
 7 January 10, 2019  11:30-12:30  Janet Simons  Using the R Programming Language to Leverage Laboratory Data Sets 
 8 January 24, 2019  11:30-12:30  Darci R. Block Validating Body Fluid Tests in the Clinical Chemistry Laboratory
 9 February 7, 2019  14:00-15:00  Joseph Alpert  CSCC Lectureship on Cardiovascular Disease 
 10 February 21. 2019  11:30-12:30  Kika Veljkovic 
Danijela Konforte
Validation and Implementation of Automated Analyzers Across Multiple Sites - a practical approach
 11 March 7, 2019 11:30-12:30  Stephanie Booth CSCC Lectureship on Critical Care 
 12 March 21, 2019  14:00-15:00  Julie Shaw & Allison Venner  Management of POCT-CSCC Guidelines 
 13 April 4, 2019  11:30-12:30  Kelly Doyle Implementation of a Sensitive and Specific Pediatric Drug Testing Protocol 
 14 April 18, 2019  14:00-15:00  Brad Urquhart  Metabolomics to Discover Biomarkers of Kidney Disease 
 15 May 2, 2019  11:30-12:00  CACB Fellows   
 16 May 16, 2019  11:30-12:30  Joseph Macri  Fecal Calprotectin 
 17 May 30, 2019  14:00-15:00  Jason Baron Artificial Intelligence 

  

#14 April 18, 2019 Metabolomics to Discover Biomarkers of Kidney Disease
Description: Chronic kidney disease (CKD) is typically diagnosed by evaluating levels of serum creatinine. Creatinine is known to have many limitations for diagnosing CKD and it is well appreciated that better biomarkers of disease are needed. In this presentation, we will discuss the use of metabolomics to identify novel biomarkers of kidney disease.
Learning Objectives: At the end of this session, participants will be able to;
1)  describe metabolomics and how it can be used in biomarker discovery
2)  list at least 3 potential novel biomarkers of chronic kidnew disease.
Speaker: Brad Urquhart, PhD, Associate Professor, Western University, London ON
#13 April 4, 2019 Implementation of a Sensitive and Specific Pediatric Drug Testing Protocol
Description:

The rate of pediatric drug exposure across the US continually increased in incidence over the last two decades. Most significant are rates of in utero drug exposure with concomitant increase in neonatal abstinence syndrome, and incidence of teenagers using drugs to self-harm or experimenting with traditional and novel psychoactive substances. Unfortunately, clinical urine drug testing was established on the premise of adult drug exposure and screening in the workplace. Immunoassay screen cutoffs are therefore not sufficiently sensitive to detect the presence of toxic drugs in pediatric patients. 

The aim of this presentation is to discuss a protocol we developed to improve clinical sensitivity by leveraging mass spectrometry and lowering thresholds in immunoassays to mitigate reporting false negative results in pediatric patients.

Learning Objectives: At the end of this session, participants will be able to:
1)  describe the shortcomings of using conventional drug screens in pediatric settings;
2)  organize an effort with pediatric specialists to develop a protocol for a needs-based drug testing protocol for pediatric patients.
Speaker: Kelly Doyle, PhD, D(ABCC), FAACC, Clinical Chemist, Intermountain Healthcare, Utah
#10 February 21, 2019 Validation and Implementation of Automated Analyzers Across Multiple Sites - a practical approach
Description: This session will discuss a practical approach to successful validation and implementation of multiple automated analyzers across multiple laboratory sites. With current trends in integration of laboratories into large healthcare systems, and standardization of laboratory practices, laboratorians are often challenged to provide adequate assessment of analytical performance and comparable patient results across multiple laboratory sites. Using a real-life case study of validation of multiple chemistry and immunochemistry analyzers in a high volume, 5-site Canadian laboratory, participants will be provided with an overview of necessary steps in successful implementation of automated analyzers across laboratory sites.
Learning Objectives: At the end of this session, participants will be able to:
1)  Describe planning and practical considerations for management of multi-site multi-analyzer validation
2)  Compare options for specific validation studies included in comprehensive analytical validation, as well as automation and IT evaluation.
3)  Choose processes required in their laboratories for successful “go-live” across multiple sites.
Speaker: Kika Veljkovic, MD, PhD, Clinical Biochemist, Lifelabs
Danijela Konforte, PhD, Clinical Biochemist, Lifelabs
#08 January 24, 2019 Validating Body Fluid Tests in the Clinical Chemistry Laboratory
Description: Body fluid testing in the clinical chemistry laboratory is a vital and necessary service. Most instrument manufacturers/methods available to do this testing are not approved for testing non-serum/plasma/urine specimens. This session will present the regulatory requirements and an approach to performing a body fluid validation for the clinical chemistry lab.
Learning Objectives: At the end of this session, participants will be able to:
1)  List regulatory requirements for body fluid validation
2)  Justify the need for body fluid validation
3)  Design and plan experiments for a body fluid validation project
4)  Evaluate methods to identify matrix interferences that may be unique to body fluids
Speaker: Darci R. Block, PhD, DABCC, Assistant Professor Laboratory Medicine and Pathology, Mayo Clinic
January 10, 2019 Using the R Programming Language to Leverage Laboratory Data Sets
Description: This session will introduce participants to the R programming language and show examples of how this tool can be used to leverage laboratory data into actionable insights which can be used to support continuous quality improvement projects, daily laboratory operations, and utilization management initiatives.
Learning Objectives: At the end of this session, participants will be able to:
1)  use the R programming language to import laboratory data and perform basic data manipulation and summary tasks
2)  describe more advanced tasks such as report production, interactive data visualization, and complex data processing which can be achieved in the R language
3)  list resources which that can access to learn more about how to use the R programming language.
Speaker: Dr. Janet Simons, Medical Biochemist, Providence Health Care 
December 6, 2018 Harmonized Reference Intervals...Holy grail or wishful thinking?
Description: Harmonized reference intervals have become a topic of great interest due to the potential for increased patient safety, reduced physician uncertainty and decreased laboratory testing due to duplicate ordering.  Several areas in the world have implemented harmonized reference intervals using different approaches.  The strengths and weaknesses of each approach will be described as well as the experience of the author in implementing harmonized reference intervals in various situations.  The work of the CSCC Task Force on harmonized reference intervals will be described.
Learning Objectives: At the end of this session, participants will be able to:
1)  identify methods for determining reference intervals
2)  identify the desirability of harmonized reference intervals (hRI)
3)  identify the challenges in deriving harmonized reference intervals
Speaker: Trefor Higgins, Zone Director of Clinical Biochemistry (Edmonton Zone), University of Alberta Hospital, Edmonton AB
#5 November 22, 2018 The Role of Troponin Algorithms in Diagnosis of Acute Coronary Syndrome
Description: The development of higher sensitivity troponin assays has allowed a significant reduction in the time to rule-out or rule-in of an acute myocardial infarction. One of the most important peices is the development of timed troponin algorithms. Currently available timed troponin algorithms will be discussed in the contaxt of European and North American guidelines.
Learning Objectives: At the end of this session, participants will be able to:
1)  be familiar with the most current definition of an MI and available guidelines
2)  review the current literature on troponin algorithms for diagnosis of ACS
3)  review the experiences of a multi-site implementation of hs-cTn and a 3-hour diagnostic algorithm
4)  assemble the tools necessary to implement a troponin algorithm in your own centre.
Speaker: Ronald A. Booth, PhD, FCACB, Associate Professor & Clinical Biochemist, University of Ottawa & Ottawa Hospital
#4 November 8, 2018 Cell Free Circulating Tumour DNA: Applications in Oncology
Description: This presentation will provide an update on the current applications for cell free circulating tumor DNA (ctDNA) in oncology, particularly for solid tumors.  Methods for isolation of ctDNA, and for detection of ctDNA by ddPCR and NGS, will be discussed.  The experience of the UHN Genome Diagnostic labs in validating and implementing ctDNA testing for non-small cell lung cancer will be described.  Future applications for ctDNA in oncology will also be discussed.
Learning Objectives: At the end of this session, participants will be able to:
1)  Outline the current molecular methods for isolation and detection of cell free circulating tumour DNA (ctCNA) for oncology applications, particularly solid tumours
2)  describe the UHN experience in using ctDNA for monitoring treatment resistance in non-small cell lung cancer (NSCLC)
3)  identify issues to consider in other applications of ctDNA in oncology.
Speaker: Tracy Stockley, PhD, Director, Genome Diagnostics, University Health Network, Toronto ON
#3 October 25, 2018 Introduction to Genomics
Description:  The roundtable will present an overview of
1)  different methods in Genomic testing and their advantages and limitations
2)  where and how Genomic testing can make a true impact in clinical care 
Learning Objectives:  At the end of this session, participants will be able to:
1)  have knowledge of the scope and limitations of different genomic methods
2)  have knowledge of the areas where genomics can play a clinical role today. 
Speaker: Dr. Hans Frykman, Medical Director, Neurocode Labs and UBC, Vancouver
#2 October 11, 2018 A New National Program for Quality Indicators Monitoring in Laboratory Medicine
Description: Quality improvement is a priority for our laboratories.  Monitoring quality indicators is essential to insure the highest standards for our patients.  The Société Québécoise de Biologie Clinique launched in 2017 a provincial program for quality indicators monitoring.  A web-based platform was developed for management of registration, data submission, production of personalized reports and more.  64 laboratories across the province are already enrolled.  Collaborating with the Canadian Society of Clinical Chemists, we are glad to open our free program all across Canada.  Collaborating with the IFCC, data will be shared with the Working Group on Laboratory Errors and Patient Safety, providing local, national and international comparison to our users.
Learning Objectives: At the end of the session, participants will be able to:
1)   Learn about the new national program for quality indicators monitoring
2)   Understand how local initiatives, part of a more global solution can maximize adhesion of laboratories to the use of quality indicators.
Speaker: Dr. Vincent De Guire, Clinical Biochemist, Maisonneuve-Rosemont Hospital, Montreal
#1 September 27, 2018 The Need for Clinical Pathology Consultation in Primary Care
Description: Primary care physicians face many challenges in their daily practice, mainly due to the limited time they have with their patients.  With regards to laboratory testing, there is limited time to research which lab tests are best for their patients.  This leads to over and underutililization of lab testing which often leads to a delay in diagnosis or misdiagnosis.  Clinical Pathologists have the potential to help primary care providers improve these two issues so that patients are diagnosed in a timely manner.  This presentation will provide several examples in daily practice where input from a clinical pathologist would be valuable.  In addition, Dr. Segal provides several examples of potential solutions to these challenges, some of which have been implemented already and others that are in progress.
Learning Objectives: At the conclusion of this session, participants will be able to:
1)  understand the challenges in the diagnostic process in today's medical environment.  Because of the challenges, there is over and underutilization of the clinical laboratory which can lead to misdiagnosis and/or delayed diagnosis.
2)  Laboratory tests involve complex biochemistry that if not interpreted in the right clinical context may lead the clinician down the wrong path (pun intended)
3)  Identify how a Clinical Pathologist can have a tremendous positive influence in improving the diagnostic process.
Speaker:  Graham Segal MD, Assistant Professor, McGovern Medical School - UT Houston